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Normal mammalian brain aging is characterized by
the selective loss of discrete populations of dendritic
spines and synapses, particularly affecting neuroan-
atomical regions such as the hippocampus. Although
previous investigations have quantified this morpho-
logically, the molecular pathways orchestrating
preferential synaptic vulnerability remain to be
elucidated. Using quantitative proteomics and
healthy rhesus macaque and human patient brain
regional tissues, we have comprehensively profiled
the temporal expression of the synaptic proteome
throughout the adult lifespan in differentially vulner-
able brain regions. Comparative profiling of hippo-
campal (age vulnerable) and occipital cortex (age
resistant) synapses revealed discrete and dynamic
alterations in the synaptic proteome, which appear
unequivocally conserved between species. The gen-
eration of these unique and important datasets will
aid in delineating the molecular mechanisms under-
pinning primate brain aging, in addition to decipher-
ing the regulatory biochemical cascades governing
neurodegenerative disease pathogenesis.
INTRODUCTION
The loss and dysfunction of selected populations of synapses is
a characteristic feature of mammalian brain aging, and alter-
ations in these receptive compartments are considered to un-
derpin age-related cognitive decline (Morrison and Baxter,
2012; Burke and Barnes, 2006; Small et al., 2004; Peters,
2002; Hof et al., 2000, 2002). It is well established that the hippo-
campal synaptic architecture displays a particular vulnerability to
a range of stimuli during advancing age (Morrison and Baxter,1018 Cell Reports 27, 1018–1026, April 23, 2019 ª 2019 The Author(s
This is an open access article under the CC BY license (http://creative2012; Burke and Barnes, 2006; Small et al., 2004), whereas pop-
ulations of synapses resident to the occipital cortex exhibit resis-
tance to age-related alterations (Peters, 2002; Hof et al., 2000,
2002; Papazafiri et al., 1995; Braak and Braak, 1995; Clare
et al., 2010; Clinton et al., 1994; Pikkarainen et al., 2009; Jo-
sephs, 2007; Fjell et al., 2015). Although the synaptic alterations
underpinning age-related cognitive decline differ from the exten-
sive neuronal loss that leads to dementia and Alzheimer’s dis-
ease (AD), these alterationsmay render neuronsmore vulnerable
to degeneration during the aging process (Morrison and Baxter,
2012; Gillingwater and Wishart, 2013). An essential area for
investigation is to determine how synaptic alterations may leave
a neuron vulnerable to neurodegeneration and the pathological
substrates promoting such vulnerability. A great deal of our
knowledge concerning the mechanisms of cognitive and brain
aging has been provided by rodent studies. Several investiga-
tions have reported heterogeneous expression of the hippocam-
pal synaptic proteome in aging rodents (Ve´gh et al., 2014; Sato
et al., 2005; VanGuilder et al., 2010); however, it has been estab-
lished that relatively few age-related gene and protein expres-
sion alterations demonstrate conservation from mouse to man
(Loerch et al., 2008). Evolutionary divergence of the primate cor-
tex has promoted functional neuronal alterations that are
uniquely primate (Morrison and Baxter, 2012), and studies doc-
umenting rodent biological brain aging are not necessarily repre-
sentative of the complex processes occurring in the human
patient, particularly with regards to selective synaptic vulnera-
bility (Loerch et al., 2008). Thus, to tease apart human age-
related cognitive decline, non-human primates (NHPs) provide
obvious advantages. NHPs are phylogenetically closer to hu-
mans and possess distinctly primate morphological, endocrine,
behavioral, and cognitive traits (Morrison and Baxter, 2012; Hof
et al., 2002), in addition to an increased lifespan, which may pro-
vide data uniquely relevant to human aging.
In what appears to be the first investigation into the regional
diversity of the primate synaptic proteome during the adult life-
span, we present a comprehensive synaptic atlas supporting).
commons.org/licenses/by/4.0/).
(legend on next page)
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the notion that local biochemical alterations likely dictate
selective synaptic vulnerability. Temporal proteomic profiling of
anatomically distinct age-resistant (occipital cortex) and age-
vulnerable (hippocampus) brain regions from the healthy NHP
revealed discrete and dynamic alterations in the synaptic prote-
ome, which appear unequivocally conserved in human patients.
Spatiotemporal examination of the age-resistant and age-vulner-
able synapses using sophisticated in silico analyses revealed
numerous candidates associated with the age-dependent
vulnerability of both theNHPand the humanpatient hippocampal
synapticmilieu.Wedemonstrate that several of these candidates
are constituents of the transforming growth factor b1 (TGF-b1)
signaling cascade and that selective activation of TGF-b1
signaling likely mediates the age-dependent vulnerability of
both the NHP and the human patient hippocampal synapse.
RESULTS
Proteomic Characterization of Anatomically Defined
NHP and Human Patient Synapses
Although it has been well documented that anatomically discrete
neuronal populations exhibit divergent levels of vulnerability to
age-related alterations during aging, the molecular correlates
governing such processes remain to be elucidated. Studies doc-
umenting neuronal alterations in primates demonstrate that the
occipital cortex appears to be the least affected brain region dur-
ing aging, with preservation of total neuronal numbers in NHPs
(Hof et al., 2000) and volumetric preservation in aged human pa-
tients (Raz et al., 2004). Conversely, perturbations in the hippo-
campal architecture are often associated with advancing age
due to the manifestation of Alzheimer’s disease in this region
(Peters, 2006). Thus, there appears to be a divergent spectrum
of synaptic vulnerability uponwhich the occipital cortex opposes
the hippocampus. To determine age-dependent regional molec-
ular alterations occurring in synaptic compartments of the
healthy NHP and human patient brain, we initially purified and
characterized isolated synaptic preparations (synaptosomes)Figure 1. Regional Characterization of the Synaptic Proteome
(A) Schematic illustrating the experimental design for comparison of differentially
OCC, occipital cortex.
(B) Venn diagrams demonstrating regional characterization of the synaptic prote
time points in each regional analysis during the time course of synaptic aging. Pro
change across the time course, and 1 unique peptide to obtain the proteins that de
up- or downregulated by >1.2 fold change during the aging time course is indicate
(C) Purity of regional synaptic preparations. Purity of regional synaptic isolates w
teomic data and isolated cortical mitochondria. Comparative expression of the s
regional preparations.
(D and E) Validation of regional temporal proteomic data with quantitative fluoresc
control for pooled hippocampal and occipital NHP synaptosomes. Samples were
difference in totalproteinbetweenagesor regions. (ii–iv) Leftbarchartdisplays thep
during aging. Right bar chart demonstrates sample protein expression quantified
(hippocampal NDUFS5 [ii], hippocampal OGDH [iii], and occipital cortex OGDH [iv
(E) (i) bIII-tubulin loading control demonstrating equivalent expression between ind
in bIII-tubulin expression between pooled samples. (ii and iii) Upper bar charts disp
synthase (ii) and ROCK2 (iii) in regional synapses during aging. Lower bar charts
blots shown. Proteomic and sample expression of both citrate synthase and RO
YH, young hippocampus; MH, mid-age hippocampus; OH, old hippocampus; YO
cortex. Statistical analyses used unpaired two-tailed Student’s t test (**p < 0.01;
See Figure S1 for further details.
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hippocampus) at 3 time points (young adult, mid-age, and old).
Quantitative label-free proteomic analyses identified >1,700 pro-
teins in each region across the time course, revealing dynamic
variations in synaptic protein expression. More than 740 proteins
were altered by greater than 20% in each discrete region (Fig-
ure 1B), demonstrating significant age-dependent biochemical
adaptations in both the NHP and the human patient brain.
The purity of regional synaptic preparations was verified with
quantitative enrichment analyses using the raw proteomic data
(Figures 1C and S1). The normalized average abundance of the
well-established synaptic markers synaptic vesicle glycoprotein
2A (SV2A) and synapsin-1 was calculated for each region at the
young time point and compared to isolated cortical mitochondria
of the same age. To ensure parity between the synaptic samples
and the isolatedmitochondria, all preparations were loaded onto
the mass spectrometer during the same experiment. SV2A
and synapsin-1 levels indicated significant enrichment in all
respective NHP and human samples versus isolated cortical
mitochondria, suggesting purification of synaptic compartments
(Figure 1C). In addition to demonstrating purification of synaptic
fractions, we employed quantitative fluorescent western blotting
(QFWB) to determine the veracity of the proteomic data. We
observed corresponding protein expression trends in each tissue
preparation, as indicated by the proteomics, for multiple proteins
(Figures 1D and 1E). Altogether, these results indicate the relative
purity of the synaptic preparations and suggest the proteomic
data are representative of the molecular alterations occurring in
both NHP and human tissues during aging. To our knowledge,
this is the first study to report brain-regional proteomic profiling
of primate synapses during the time course of aging.
Regional Heterogeneity in the Synaptic Proteome Is
Conserved between Aging NHPs and Aging Human
Patients
To address the question of regional vulnerability, we initially
sought to determine whether synapses from discrete brainvulnerable brain regions throughout the aging time course. HC, hippocampus;
ome. Venn diagrams display the total number of proteins identified at discrete
teins were filtered in Progenesis using the following criteria: p > 0.05, <1.2 fold
monstrate the largest alterations during aging. Number of proteins significantly
d at the middle intersection. These filtered proteins were used for all analyses.
as verified with quantitative enrichment analyses using the raw regional pro-
ynaptic markers SV2A and synaptotagmin indicate synaptic enrichment of all
ent western blotting in NHP (D) and human patient (E) samples. (i) Actin loading
pooled according to age group. Bar charts demonstrate there is no significant
roteomicaveragenormalizedexpressionvaluesof proteins in regional synapses
by fluorescent western blots. Proteomic and sample expression of all proteins
]) follow the same trend, thereby providing validation of the proteomic data.
ividual patients and between regions. Graph displays no significant difference
lay the proteomic average normalized expression values of the proteins citrate
demonstrate sample protein expression quantified by the fluorescent western
CK2 follow the same trend, thereby confirming the proteomic data.
, young occipital cortex; MO, mid-age occipital cortex; OO, old age occipital
***p < 0.001; ****p < 0.0001).
Figure 2. Distinct Clustering Patterns Are
Conserved in Human Patient Synapses
(A and B) Regional protein-protein correlation
networks displaying proteins significantly altered
through the time course of aging in NHPs (A) and
human patients (B). Nodes signify individual pro-
teins, and edges reflect the strength of correlation
of expression. Colors represent clusters of pro-
teins that are grouped together based on their
expression profiles. Correlation networks appear
to be conserved in synaptosomes from human
patients during normal healthy aging. Graphs are
clustered using Pearson r = 0.95.
See Figures S1 and S2 for further details.regions aged in a similar manner in both NHPs and human
patients. Using the objective network visualization software
BioLayout Express3D (Theocharidis et al., 2009), we generated
brain regional Pearson correlation graphs, in addition to
principal-component analyses (PCAs) and heatmaps, demon-
strating relative age-dependent similarities (Figure S1). Examina-
tion of the Pearson correlation networks and PCAs confirmed
distinct region-dependent clustering profiles. Resistant NHP
synaptic populations (occipital cortex) exhibited single net-
works, suggesting congruence among young, mid-age, and
old samples (Figure S1); however, the aged synaptic population
appears to demonstrate reduced equivalence with the mid-age
synapses and enhanced similitude with the young samples (Fig-
ures S1 and S2). Similarly, the human patient occipital cortex
Pearson correlation graph and PCA biplot demonstrate that
mid-age synaptic isolates exhibit reduced correspondence
with the young and old time points (Figures S1 and S2). The
salient similarities in protein expression between the young
and the old occipital cortex synaptic populations may confer
resistance to insult during advancing age. Conversely, vulner-
able synaptic populations (hippocampus) display fragmentation
into 2 smaller networks in both the NHP and the human patient,
indicating age-dependent heterogeneity (Figures S1 and S2).
Although there appears to be a small degree of variability
between the young and the mid-age samples in the NHP (Fig-
ure S2), it is evident that the aged hippocampal synaptic popula-
tion possesses discrete protein expression profiles (Figures S1
and S2), which appear to be conserved in the corresponding hu-
man patient samples andmay be relevant to the vulnerability sta-
tus of hippocampal synapses at this particular age (Figure S2).
Thus, there are indications that isolated synaptic populationsCell Rage in a region-dependent manner and
these unique alterations may reflect the
potential vulnerability of synapses, inde-
pendent of primate species.
Regional Profiling of Aging Primate
Synapses Reveals Protein
Expression Trends Correlating with
Synaptic Vulnerability
In conjunction with the Pearson correla-
tion graphs and PCAs, to dissect region-
specific, age-dependent synaptic alter-ations, we generated network graphs of the regional time course
proteomic data, again using BioLayout Express3D (Theocharidis
et al., 2009). The software applies unbiasedMarkov clustering al-
gorithms to the input data and groups proteins displaying similar
expression trends. This allows visualization of spatiotemporal
profiles promoting the identification of physiological cascades
altered within the dataset. Graphs were constructed using
regional differentially expressed proteins (altered >20%) through
the time course of aging (Figure 1B), providing 20–30 clusters per
region. In agreement with the Pearson correlation graphs and
PCAs, network clustering of the proteomic data displayed similar
trends with regards to fragmentation of the graphs representing
the vulnerable brain regions (hippocampus), whereas synaptic
isolates considered resistant during aging appear as one large
network (occipital cortex) (Figure 2A). Proteomic data character-
izing aging synaptic isolates from human post-mortem samples
at equivalent ages to the NHP (young, mid-age, and old) display
similar network clustering profiles (Figure 2B). Significant demar-
cation remains between the occipital cortex and the hippocam-
pus, suggesting resistant and vulnerable brain regions are aging
in unique manners in both NHPs and human patients (Figures 2A
and 2B). Furthermore, the results suggest that the regional NHP
datamay be an accurate reflection of human synaptic aging, with
clear conservation of protein expression alterations during the
time course.
Byusing twocontrasting brain regionsdemonstrating disparate
profiles of aging in both NHPs and human patients, we aimed to
identify conserved regulators of synaptic vulnerability with com-
parisonofanalogousproteinexpressionprofiles.Clustersdisplay-
ing particular expression trends of interest were selected from
both the NHP and the human patient occipital cortex andeports 27, 1018–1026, April 23, 2019 1021
hippocampus synaptic time course data using BioLayout
Express3D (Figure 3A, 3B, 3E, and 3F). Those exhibiting steady
up- or downregulation protein expression profiles during the
time course were considered potential biomarkers of normal
healthy aging due to the predictable age-dependent tractability
of thosecandidates (Figures3Aand3E) (for clusterenrichment an-
alyses, see Figure S3). Conversely, proteins displaying late-stage
increases or decreases in expression were regarded as potential
correlatesof regional vulnerability, because theabrupt expression
changes observed in the old synaptic populations likely reflected
acute alterations disrupting homeostasis at the synapse (Figures
3B and 3F) (for cluster enrichment analyses, see Figure S3). To
identify candidates that may be regulating regional synaptic
vulnerability during aging in both the NHP and the human patient,
proteins from occipital and hippocampal clusters with analogous
expression profiles were subject to a subtractive process. Pro-
teinsdemonstrating equivalent spatiotemporal profiles inboth oc-
cipital cortex and hippocampal synapses were not considered
likely regulators of differential regional synaptic vulnerability and
filtered from the data before further analysis (Figures 3C, 3D, 3G,
and 3H). Upon subtraction of proteins exhibiting analogous
expression profiles, there remained 241 differentially expressed
proteins in the NHP analysis and 386 differentially expressed pro-
teins in the human analysis, all of which we tracked through
regional aging (Figures 4A and 4B).
The TGF-b1 Signaling Pathway Is a Conserved Cascade
Associated with Hippocampal Synaptic Vulnerability in
Both Aged NHPs and Human Patients
Althoughwehadcharacterized spatiotemporal alterationsoccur-
ring in populations of differentially vulnerable synapses on a
global scale, it remained unclear whether the regional divergence
in expression of individual candidate proteins may be capable of
actively regulating synaptic vulnerability. We reasoned that can-
didates likely modulating alterations in the stability of the syn-
apse, particularly at old age, would exhibit unequivocal regional
temporal profiles. Proteins with corresponding regional expres-
sion at the young and mid-age time points followed by a signifi-
cant demarcation in expression at old age were selected as
potential regulators of synaptic vulnerability—these particular
expression profiles correlate with previous reports of significant
alterations in synapse electrophysiological properties and
morphometry in the aged rhesus monkey hippocampus (Morri-
son and Baxter, 2012; Peters et al., 2008). With characterization
of the 241 filtered proteins from the NHP analysis (Figure 4A)
and 386 proteins from the human time course (Figure 4B), we
identified 17 candidates (NHP candidates: RCN2, CAPZA2,
CYC1, OGDH, ROCK2, and CDH2; human candidates:
CDC42EP4, STMN3, IGKC, CD99, SLC7A5, APOA1, HCN2,
PPT1, FKBP4, HEBP1, andPDAP1) that displayed the archetypal
regional spatiotemporal expression profile (Figures 4A and 4B).
Thus, these data represent a physiologically relevant paradigm
demonstrating that alterations in the expression of these candi-
dates in the NHP and/or human hippocampus may correlate
with selective synaptic vulnerability during aging.
Despite presenting several candidates that may have the pro-
pensity to alter synaptic morphometry in both NHPs and human
patients, it is unlikely that the expression of single proteins solely1022 Cell Reports 27, 1018–1026, April 23, 2019regulate regional synapse vulnerability during mammalian brain
aging. Instead, it is probable that multiple cellular and molecular
pathways up- and downstream of the identified candidates
converge to regulate age-dependent alterations in synaptic
structure and function. By employing Ingenuity Pathway Analysis
(IPA) software, we sought to identify common upstream master
regulators that may be modulating the expression of the NHP
or human patient candidates simultaneously. Despite presenting
distinct candidates that may be associated with NHP (RCN2,
CAPZA2, CYC1, OGDH, ROCK2, and CDH2) (Figure 4A) or hu-
man patient (CDC42EP4, STMN3, IGKC, CD99, SLC7A5,
APOA1, HCN2, PPT1, FKBP4, HEBP1, and PDAP1) (Figure 4B)
age-dependent hippocampal synaptic vulnerability, upstream
analyses highlighted that the identified candidates from both
the NHP and the human patient datasets appeared to sit down-
stream of the microglial cytokine TGF-b1 in the hierarchical
cellular signaling cascade (Figures 4C and 4D). With further ex-
amination, we established that this particular pathway demon-
strated conserved activation in both aged NHP and aged human
patient hippocampal synapses, promoting concomitant per-
turbed expression of our identified candidate proteins (Figures
4C and 4D). Both NHP and human patient occipital cortex syn-
apses of the equivalent age exhibited differential regulation of
this pathway, with TGF-b1 showing significant inhibition (Figures
4C and 4D). Thus, there are suggestions that the activation sta-
tus of TGF-b1 signaling in discrete populations of synapses may
be contributing to differential synaptic vulnerability in both NHPs
and human patients. TGF-b1 is not constitutively expressed in
neurons but instead displays robust levels of expression in mi-
croglia (Figure S4), suggesting that regional synaptic vulnera-
bility may be mediated by microglial signaling. Altogether, the
data demonstrate that the inherent vulnerability of aged hippo-
campal synapses may be mediated by perturbations in the
microglial TGF-b1 signaling cascade and that this is likely
conserved among various primate species.
DISCUSSION
The molecular mechanisms governing the age-dependent
decline of selected synaptic populations remain elusive, and
studies are just beginning to focus on how protein pathways
may synergistically or hierarchically drive this phenomenon.
The current investigation is the first of its kind and has enabled
the generation of a unique synaptic atlas documenting the
age- and region-dependent alterations occurring in the human
patient and NHP brain. This comprehensive proteomic profiling
has provided a unique insight into how differential age-depen-
dent synaptic vulnerability may be modulated, which may have
implications for the field of neurodegenerative diseases. The
thorough molecular mapping of both primate species has pro-
vided an accessible and dynamic temporal synaptic map to
which we may compare disease processes, allowing elucidation
of biochemical alterations that may be regarded as pathogenic.
The TGF-b1 Signaling Cascade: A Synaptic-Microglial
Intersection?
The identification of fundamental biochemical pathways orches-
trating selective synaptic vulnerability is imperative for the
Figure 3. Temporal Profiling of Discrete Synaptic Populations Reveals Biomarkers of Aging and Vulnerability
(A and E) Biomarkers of aging: example temporal expression profiles of proteins demonstrating steady up- or downregulation during aging in the NHP (A) or
human patient (E).
(B and F) Biomarkers of vulnerability: example clusters displaying late-stage increases or decreases in temporal protein expression in the NHP (B) or human
patient (F). All graphs were generated in BioLayout Express3D (r = 0.95) and display the mean protein expression across the time course in occipital and hip-
pocampal synaptic isolates in both NHPs and human patients.
(C, D, G, and H) Venn diagrams indicating subtraction of candidates. Proteins demonstrating equivalent spatiotemporal profiles in both occipital cortex and
hippocampal synapses (shown at the intersection) were not considered regulators of differential regional synaptic vulnerability and were subtracted from further
analysis in both the NHP time course (C and D) and the human patient data (G and H).
YH, young hippocampus; MH, mid-age hippocampus; OH, old hippocampus; YO, young occipital cortex; MO, mid-age occipital cortex; OO, old age occipital
cortex. Numbers refer to sample technical replicates.
See Figure S3 for further details.
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Figure 4. Identification of Potential Candidates and Upstream Regulators Capable of Modulating Synaptic Vulnerability during Aging in the
NHP and the Human Patient
(A and B) Right: heatmaps displaying average normalized abundance values of 241 (A) and 386 (B) differentially expressed candidates associated with synaptic
vulnerability in both the NHP (A) and the human patient (B). Left: identification of proteins that may have the propensity tomodulate regional synaptic vulnerability.
Graphs represent temporal expression profiles of selected candidates that likely modulate hippocampal synaptic stability with advancing age. Note the similar
expression profiles through young and mid-age in both resistant and vulnerable synaptic compartments, followed by significant divergence in expression at old
age. Heatmaps: blue, low expression; red, high expression. Candidate graphs: purple, hippocampal candidate expression during aging; gray, occipital cortex
candidate expression during aging.
(C and D) Ingenuity Pathway Analysis (IPA) software highlights TGF-b1 as a conserved common upstream regulator to identified candidates from both the aging
NHP (C) and the aging human patient (D) synaptic vulnerability analyses. The TGF-b1 signaling cascade displays significant activation in vulnerable hippocampal
synaptic populations at old age, promoting perturbations in candidate expression. Conversely, TGF-b1 signaling appears inhibited in the age-resistant occipital
cortex synapses in both NHPs (C) and humans (D). Positive Z scores indicate activation (orange), and negative Z scores indicate inhibition (blue); green represents
downregulation relative to the expression in young animals.
See Figure S4 for further details.
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development of neuroprotective strategies. The current investiga-
tion suggests there is scope to detect inherent protectivemodula-
tors, leading to the amelioration of synaptic dysfunction. Despite
the candidates displaying significant diversity in localization and
function at the synapse, multiple proteins, identified from both
the NHP and the human patient analyses, demonstrated a com-
mon upstream regulator: TGF-b1. TGF-b1 is not constitutively
expressed in neurons but instead displays robust levels of expres-
sion in microglia (Figure S4A) suggesting that regional synaptic
vulnerability may be mediated by microglial signaling. Investiga-
tions have reported age- and region-dependent microglial diver-
sity at the transcriptome level, with indications that hippocampal
microglia exhibit compromised function with advancing age (Gra-
bert et al., 2016). In conjunction, immunohistochemical tech-
niques have revealed that microglial populations in aged NHP
models and human patients appear to display a dystrophic
morphology (Streit et al., 2004). In conjunction with this senescent
phenotype, there is abundant evidence to suggest that microglia
become hypersensitive or primed, resulting in prolonged pro-in-
flammatory activation in response to homeostatic alterations
(Fan et al., 2017; Udeochu et al., 2016), which may functionally
contribute to age-related neuronal alterations via modifications
in cytokine signaling and immuno-surveillance (Damani et al.,
2011). Furthermore, investigations into the pathogenic role of mi-
croglia have documented chronic overexpression of TGF-b1 in
multiple neurodegenerative diseases, including Alzheimer’s dis-
ease, frontotemporal dementia (FTD), amyotrophic lateral scle-
rosis (ALS), and Parkinson’s disease (PD) (Martinez-Canabal
et al., 2013; Wirths et al., 2010), illustrating that this pathway
may be contributing to numerous age-related diseases in which
the synapse is an early pathological target.
Based on this evidence, it is perhaps unsurprising that our
data have described microglial TGF-b1 signaling as a potential
modulator of regional synaptic vulnerability during aging. Micro-
glia and synapses are notmutually exclusive entities, and there is
a requirement for a dynamic and bidirectional relationship to
enable homeostatic control of the cellular milieu; however, this
critical intersection appears to be potentiating age-dependent
instability in the hippocampal synaptic architecture. Despite
the wealth of data presented in this study, the cause-conse-
quence relationship underpinning selective synaptic vulnerability
remains unresolved. It is unclear whether (1) disruptions in syn-
aptic proteostasis precede aberrant microglial TGF-b1 signaling
or (2) microglia are the primary effectors and activation of
TGF-b1 signaling facilitates synaptic dysfunction. However, we
may speculate that the latter appears to be the most compelling
hypothesis, because restoration of upstreammicroglial signaling
promotes synaptic protection in multiple models of aging (Hong
et al., 2016; Shi et al., 2017; Daria et al., 2017).
Cumulatively, our data provide comprehensive insight into the
regional heterogeneity of synaptic aging and how proteostatic al-
terationsmaydictateselectivesynaptic vulnerability in theprimate.
Identification of the microglial cytokine TGF-b1 as a master regu-
lator of hippocampal synapse structure and function is indicative
of a highly dynamic cohesive cellular network that requires symbi-
otic modulation for optimal neuronal function during advancing
age. Despite this, the implicit role of the TGF-b1 cascade in
regional synaptic vulnerability is not unequivocal. It remains un-clear whether activation of TGF-b1 signaling is uniquely maladap-
tive to selected synaptic populations or whether discrete target
tissues demonstrate varied allostatic loads. Furthermore, a signif-
icant chasm in scientific knowledge concerningmicroglial-synap-
tic interactions during advancing age persists, and this must be
addressed before we can fully appreciate the functional patho-
physiology of age-related cognitive decline.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
BetaIII-tubulin Abcam Cat: ab18207; RRID:AB_444319
NDUFS5 ProteinTech Cat: 15224-1-AP; RRID:AB_2149021
OGDH ProteinTech Cat: 15212-1-AP; RRID:AB_2156759
ROCK2 Abcam Cat: ab71598; RRID:AB_1566688
Citrate synthase Amsbio Cat: TA310356
Goat anti-rabbit IRDye 680 Odyssey Cat: P/N 925-68071; RRID:AB_2721181
Biological Samples
Healthy rhesus macaque hippocampal tissue
blocks of varying ages: young adult (mean age = 9.5
years), mid-age (mean age = 15.6 years), old age
(mean age = 23 years); n = 4 animals per age group
Oregon National Primate
Research Center (ONPRC)
N/A
Healthy rhesus macaque occipital cortex tissue
blocks of varying ages: young adult (mean age = 9.5
years), mid-age (mean age = 15.6 years), old age
(mean age = 23 years); n = 4 animals per age group
Oregon National Primate
Research Center (ONPRC)
N/A
Healthy human patient hippocampal tissue blocks
of varying ages: young (18-25 years), mid-age (40-50
years), old age (70+ years); n = 4 samples per age group
Edinburgh Brain and Tissue Bank N/A
Healthy human patient occipital cortex tissue blocks
of varying ages: young (18-25 years), mid-age (40-50
years), old age (70+ years); n = 4 samples per age group
Edinburgh Brain and Tissue Bank N/A
Chemicals, Peptides, and Recombinant Proteins
RIPA lysis and extraction buffer Thermo Fisher Cat: 89901
Halt Protease inhibitor cocktail (100X) Thermo Fisher Cat: 87786
Critical Commercial Assays
Micro BCA protein assay kit Thermo Fisher Cat: 23235
Deposited Data
NHP hippocampal synaptic aging time course This paper https://doi.org/10.7488/ds/2431
NHP occipital cortex synaptic aging time course This paper https://doi.org/10.7488/ds/2431
Human patient hippocampal synaptic aging time course This paper https://doi.org/10.7488/ds/2431
Human patient occipital cortex synaptic aging time course This paper https://doi.org/10.7488/ds/2431
Software and Algorithms
Xcalibur Thermo Fisher Cat: OPTON-30382
Mascot V2.3.2 Matrix Science http://www.matrixscience.com
Progenesis Nonlinear Dynamics http://www.nonlinear.com
BioLayout Express3D (now known as Graphia Pro) Kajeka https://kajeka.com
Ingenuity Pathway Analysis QIAGEN https://www.qiagenbioinformatics.com/
products/ingenuity-pathway-analysisCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact,
Dr. Thomas Wishart (t.m.wishart@ed.ac.uk).Cell Reports 27, 1018–1026.e1–e4, April 23, 2019 e1
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Ethics
In compliance with the 3Rs, no animals were bred specifically for this project. All tissue samples used in the current study were
derived from existing archived brains. The Oregon Health & Sciences University Institutional Animal Care and Use Committee at
theOregonNational Primate ResearchCenter (ONPRC) approved all animal experiments and theUniversity of Edinburgh ethics com-
mittee approved the use of archived material.
Animals
Archived material from 12 rhesus macaques (Macaca mulatta) of differing sexes and ages were utilized for the studies described.
Animals were assigned to the young adult (mean age = 9.5 years), mid-age (mean age = 15.6 years) or old age (mean age = 23 years)
group, with 4 animals per time point. Tissue was historically banked following euthanasia according to procedures recommended by
the 2013 Edition of the American Veterinary Medical Association Guidelines for the Euthanasia of Animals. Each animal was sedated
with ketamine, administered pentobarbital (30 mg/kg, i.v.), and exsanguinated by severance of the descending aorta. Brains were
removed and appropriate regional dissections performed before freezing the samples in liquid nitrogen.
Human patient samples
Human patient samples of differing sexes were obtained from the Edinburgh Brain Bank. All tissues were classified as controls due to
the absence of gross pathological hallmarks and neurological disease. Human tissues were assigned to equivalent age groups:
young (18-25 years), mid-age (40-50 years) or old age (70+ years), with 4 samples per time point. Use of human tissue for post-mor-
tem studies was reviewed and approved by the Edinburgh Brain Bank ethics committee. The Edinburgh Brain Bank is a Medical
Research Council funded facility with research ethics committee approval (11/ES/0022).
METHOD DETAILS
Synaptosomal preparations
Regional brain tissue samples were homogenized in an ice-cold isotonic sucrose solution (0.32 M sucrose, 1 mM EDTA,
5 mM Tris-HCl, pH 7.4). Homogenates were centrifuged in a fixed-angle rotor at 900 g for 10 min and the supernatant (S1) was
collected. The pellet (P1) was resuspended in sucrose solution and centrifuged again at 900 g for 10 min. Supernatants were com-
bined and centrifuged in a fixed angle rotor at 20,000 g for 15 min. The remaining pellets (P2) contained the synaptosomes.
Protein concentration assay
Samples were homogenized in label-free or RIPA buffer + 1% protease cocktail inhibitor (Thermo Scientific). After homogenization,
samples were centrifuged at 20,000 g for 20 minutes at 4C. The supernatant containing the solubilised protein was removed and
pellets discarded. Protein concentration of samples was determined using a Pierce Micro BCA assay kit according to the
manufacturer’s instructions.
Label-free proteomics
Regional synaptosomal preparations were pooled by brain region and age group (for more information on proteomic methods and
the use of pools on human and/or veterinary clinical samples see (19, 27-28)) and extracted in SDT lysis buffer containing 100 mM
Tris-HCl (pH 7.6) and 4% (W/V) sodium dodecyl sulfate (VWR). For efficient protein extraction, lysates were freeze–thawed and
homogenized in SDT buffer several times. Protein concentration was then determined using BCA assay.
Aliquots (200 mg) of each individual (biological replicates) and pooled (technical replicates) synaptosomal preparation were pro-
cessed through FASP (filter-aided sample preparation) involving buffer exchange to 8 M urea and alkylation with 50 mM iodoaceta-
mide prior to a double digestion with trypsin (Roche, sequencing grade), initially for 4 h, then overnight at 30C. Trypsin-digested
peptides were separated using an Ultimate 3000 RSLC (Thermo Scientific) nanoflow LC system with the column oven set to
35C. Technical replicates (3 3 1 mg) of each pooled sample were loaded at a constant flow of 5 mL/min onto a trapping cartridge
(PepMap100, C18, 5 mm, 100A˚ 0.3 3 5 mm; (Thermo Scientific, San Jose, CA)) using 2% Acetonitrile, 0.1% formic acid. After trap
enrichment, peptides were separated on a peptide CSH, 1.7 mm, 130A˚, 75 mm x 250mmC18 column (Waters Corp, Milford, MA) with
the following gradient: t = 0 min, 2% B; t = 6, 2% B; t = 20, 8% B; t = 110, 24% B; t = 135, 37% B where solvent A is water with 0.1%
formic acid and solvent B is 80% acetonitrile with 0.1% formic acid, with a constant flow of 260 nL/min. The HPLC system was
coupled to a linear ion trap Orbitrap hybrid mass spectrometer (LTQ-Orbitrap Velos Pro, Thermo Scientific) via a nanoelectrospray
ion source (ThermoScientific). The spray voltagewas set to 2.2 kV, and the temperature of the heated capillary was set to 200C. Full-
scanMS survey spectra (m/z 335–1800) in profilemodewere acquired in theOrbitrap with a resolution of 60 000 after accumulation of
1 000 000 ions. A lock mass of 445.120 024 was enabled for survey scans to improve mass accuracy. The 15 most intense peptide
ions from the preview scan in the Orbitrap were fragmented by collision-induced dissociation (normalized collision energy, 35%; acti-
vationQ, 0.250; and activation time, 10ms) in the LTQ after the accumulation of 10 000 ions. Dynamic exclusion parameters were set
as follows: repeat count, 1; repeat duration, 30 s; exclusion list size, 500; exclusion duration, 45 s; exclusion mass width, plus/minuse2 Cell Reports 27, 1018–1026.e1–e4, April 23, 2019
10 ppm (relative to reference mass). Maximal filling times were 10 ms for the full scans and 100 ms for the MS/MS scans. Precursor
ion charge state screening was enabled, and all unassigned charge states as well as singly charged species were rejected. Data were
acquired using Xcalibur software.
Raw proteomic data were imported into Progenesis for characterization and analysis of relative ion abundance. 2D representations
of MS/MS output were created for each sample and these were aligned to determine similar features (average alignment score >
80%). Following alignment, data were filtered by retention time with features detected below 17 minutes and above 140 minutes
(NHP regional analysis of synaptic aging)/below 11.81 minutes and above 134.37 minutes (human patient regional analysis of syn-
aptic aging) discarded to correct for elution variability. The runs were grouped according to age and brain region and statistical
p values were calculated in Progenesis software. For calculation of statistical power and p values, the per run abundances for
each grouped experimental condition were transformed through Arc-Sinh normalization to minimize data variability. Following
this, 1-way ANOVAs were conducted on the data assigned to the pre-defined experimental conditions resulting in the generation
of reliable p values associated with each identified peptide. Peptides were filtered by the following criteria: power < 0.8, fold
change > 1.2, p > 0.05 and the remaining data were exported fromProgenesis for identification of individual peptide sequences using
the IPI-Macaca mullata (NHP regional analysis of synaptic aging) and IPI-Homo sapiens (human patient regional analysis of synaptic
aging) databases viaMascot Search Engine (V2.3.2). Enzyme specificity was set to that of trypsin, allowing for cleavage N-terminal to
proline residues and between aspartic acid and proline residues. Other parameters used were as follows. (i) Variable modifications:
methionine oxidation, methionine dioxidation, protein N-acetylation, gln/ pyro-glu. (ii) Fixedmodifications: cysteine carbamidome-
thylation. (iii) MS/MS tolerance: FTMS- 10 ppm, ITMS- 0.6 Da. (iv) Minimum peptide length: 6. (v) Maximummissed cleavages: 2. (vi)
False discovery rate: 1%. A cutoff score of > 34 was used based on Mascot probability threshold of 0.05 that the observed hit is a
random event. As an indication of identification certainty, the false discovery rate for peptide matches above identity threshold was
set at 1%. Identified proteins were re-imported into Progenesis for further processing. Proteins were subject to stringent filtering pa-
rameters to eliminate those which had < 2 unique peptides, < 1.2 fold change between age groups and p > 0.05 to obtain the proteins
which demonstrated the largest significant variation in expression over the aging time course in each brain region.
Biolayout Express3D
Proteomic data was dissected using the complex pattern recognition software, Biolayout Express3D (Theocharidis et al., 2009). The
software allows visualization of molecular networks by applying Markov clustering algorithms to raw proteomic data (MCL 2.2). All
graphs were clustered using Pearson correlation r = 0.95. Clusters of interest indicating age-dependent alterations included those
that demonstrated a steady up- or downregulation or a late stage up- or late stage downregulation during the time course of aging.
Proteins from clusters with analogous expression profiles underwent a subtractive process – candidates appearing in both the resis-
tant and vulnerable clusters, altered in the same manner, were unlikely to regulate synaptic vulnerability during aging. These candi-
dates were eliminated as modulators of synaptic vulnerability.
Ingenuity Pathway Analysis
IPA was performed as previously described (Wishart et al., 2007) with the interaction data limited as follows: direct and indirect
interactions; experimentally observed data only; 35 molecules per network; 10 networks per dataset. Prediction activation scores
(z-score) were calculated in IPA. The z-score is a statistical measure of the match between an expected relationship direction and
the observed protein expression. Positive z-scores indicate activation (orange) and negative z-scores indicate inhibition (blue)
(Savli et al., 2008).
Quantitative fluorescent western blotting
Quantitative fluorescent western blotting was performed as previously described (Eaton et al., 2013). Samples were diluted to pro-
vide desired protein concentration. 10-15 mg protein was loaded per well into Nu-PAGE Novex 4%–12% Bis Tris mini-gels (Life
Technologies) and transferred to PVDFmembranes using an iBlot and Invitrogen gel transfer stacks. Membranes were incubated in
primary antibodies at 4C and secondary antibodies at room temperature (concentrations according to manufacturer’s instructions)
before imaging on Li-COR Odyssey infrared scanner. Protein expression was quantified utilizing Odyssey software (Li-COR Biosci-
ences). Primary antibodies: BetaIII-tubulin (Abcam Cat: ab18207), NDUFS5 (ProteinTech Cat: 15224-1-AP), OGDH (ProteinTech Cat:
15212-1-AP), ROCK2 (Abcam Cat: ab71598), Citrate synthase (Origene Cat: TA310356); secondary anitbodies: Goat anti-rabbit
IRDye 680 (Odyssey).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses
For calculation of statistical power and p values from the raw proteomic data, the per run abundances for each grouped experimental
condition were transformed through Arc-Sinh normalization to minimize data variability. Following this, one-way ANOVAs were con-
ducted on the data assigned to the pre-defined experimental conditions, resulting in the generation of reliable p values associatedCell Reports 27, 1018–1026.e1–e4, April 23, 2019 e3
with each identified peptide. Peptideswere filtered by the following criteria: power < 0.8 and p > 0.05 before identification of individual
peptide sequences to ensure data harbored sufficient statistical power. For all other experiments, data were collected in Microsoft
Excel and statistical tests were performed in GraphPad Prism 6 software. For all analyses p < 0.05 was considered significant.
Statistical tests used are detailed in the results or figure legends where appropriate.
DATA AND SOFTWARE AVAILABILITY
All proteomic datasets generated and used by this study are freely available at: https://doi.org/10.7488/ds/2431e4 Cell Reports 27, 1018–1026.e1–e4, April 23, 2019
